Navigation Links
Hormone in birth control shot linked to memory loss
Date:11/1/2011

TEMPE, Ariz. The birth control shot Depo Provera offers a convenient alternative for women who don't want to remember to take a daily pill. Ironically, research from Arizona State University has shown the shot actually may impair a person's memory.

The ASU study connects medroxyprogesterone acetate (MPA), the hormone active in Depo Provera and many widely used menopausal hormone therapies, to impaired memory in rodents. The study is currently in press in the journal Psychopharmacology. An early on line version of the article is available at http://www.springerlink.com/content/53357212117581w6/.

The study was led by Blair Braden, an ASU psychology doctoral student, and Heather Bimonte-Nelson, an ASU associate professor of psychology and director of the Bimonte-Nelson Memory and Aging Lab. The work was done in collaboration with Laszlo Prokai from the University of North Texas Health Sciences Center, Fort Worth, Tex., and Alain Simard from Barrow Neurological Institute, Phoenix.

The Bimonte-Nelson lab first linked MPA to memory loss in rats while studying it as a component of hormone therapy for menopause. This earlier study showed that MPA impaired memory in menopausal-aged rats, and results were published in the November 2010 issue of Neurobiology of Learning and Memory. The current study specifically looks at the drug in relation to the birth control shot.

Bimonte-Nelson said she and Braden began asking questions about the effects of the drug because Braden was concerned about friends taking MPA as a contraceptive.

"This is an important question, because what we are going to have in our future are women who are menopausal that also have a history of taking MPA as birth control when they were younger," said Bimonte-Nelson.

The U.S. Food and Drug Administration originally approved Depo Provera for use in October 1992. It requir
'/>"/>

Contact: Skip Derra
skip.derra@asu.edu
480-965-4823
Arizona State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Obese people regain weight after dieting due to hormones
2. Hunger Hormones May Drive Post-Dieting Weight Gain
3. Research involving thyroid hormone lays foundation for more targeted drug development
4. Breast Cancer Risk May Rise With High Hormone Levels
5. Elevated hormone levels add up to increased breast cancer risk
6. Breast tenderness in women getting combo hormone therapy associated with increase in breast density
7. Shift Workers Show Rise in Stress Hormone
8. Is Female Hormone Disorder Tied to Familial Heart Risk?
9. Stress hormones may increase cardiovascular risks for shift workers
10. New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
11. Pituitary hormone TSH found to directly influence bone growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... Scientel is thrilled ... Conference, August 18-20 at the McHenry Convention Center in San Jose, Ca. Scientel ... #104. , Scientel’s presentation on Multi-Modeling and the industry’s first polymorphic database will address ...
(Date:7/27/2015)... SC (PRWEB) , ... July 28, 2015 , ... ... P.A., announced that his practice has teamed up with Realief Neuropathy Centers in order ... been shown to reverse the signs and symptoms of peripheral neuropathy. , Peripheral neuropathy ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular ... smaller regional brain volumes that may be early indicators of Alzheimer’s disease and ... already know that vascular risk factors damage the brain and can result in ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... especially in wound center management. Earlier this year Wound Care Advantage ... and training for WCA wound centers. Customized learning paths allow for clinicians, ...
(Date:7/27/2015)... ... July 27, 2015 , ... On July 14, 2015, ... Common Skin Issues,” describes common skin issues such as stretch marks , ... dermatologists to treat them. The treatment options listed include lasers, ultrasound, radio frequency, Botox, ...
Breaking Medicine News(10 mins):Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:The Latest Treatment Options for Seven Common Skin Issues 2
... availability of Trade Alerts on stocks making news ... notes for free by visiting: http://www.BeaconEquity.com/m Today,s ... Board: UVSE), Green Earth Technologies Inc. (Pink Sheets: ... Gulf Ethanol Corp. (Pink Sheets: GFET), YTB International ...
... 13 Founders Club will donate $5 from the sale ... at St. Joseph,s/Candler. "The Mammography Fund is a great ... fight against cancer," Jeff Andrews, CEO of Founders Club, said.The ... Edwin Watts Golf stores and specialty golf retail stores across ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today ... share. This dividend was declared by Hill-Rom,s Board of Directors ... 2009 to shareholders of record as of March 17, 2009. ... is a leading worldwide manufacturer and provider of medical technologies ...
... along with being sweet , , FRIDAY, Feb. 13 (HealthDay News) ... than sweet; it could help guard your true love against ... in addition to being decadent and delicious, moderate amounts of ... Scroggs, a health education manager at the University of Texas ...
... (NYSE Alternext: FHC) announced today that its stock repurchase ... until December 31, 2010. The program was initiated in ... the Company,s common stock through December 31, 2008. In ... and extended until December 31, 2009. Through January 31, ...
... announces that it has implemented cost-cutting measures in order ... will continue to seek financing and will initiate a ... of the Company. , Haemacure has been seeking financing ... expressed interest in an equity financing; however, this interest ...
Cached Medicine News:Health News:Technical Trade Alerts on BeaconEquity OTC Gainers: UVSE, GETG, SRCH, GFET, YTBLA, NTRZ 2Health News:Founders Club Proudly Supports the St. Joseph's/Candler Mammography Fund 2Health News:Chocolate for Your Valentine a Healthy Idea 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 3Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 2Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 3
(Date:7/27/2015)... 20, 2015 Research and Markets ( ... "Key Pharma News Issue" newsletter to ... Gilead Sciences, burgeoning oncology pipeline and serves as ... oncology deals in 2015, with a large-scale potentially ... Key Pharma News covers all major ...
(Date:7/27/2015)... , Belgium , July 27, ... VNRX), a life sciences company focused on developing blood-based ... and other conditions, today announced that it has engaged ... organization, Global Specimen Solutions, Inc. (GSS), to support initial ... cancer tests. Under the agreement, GSS ...
(Date:7/27/2015)... IRVINE, Calif. , July 27, 2015 ... ELOS ) , a global market leader in ... has received Korean Ministry of Food and Drug Safety ... this regulatory clearance, the Company can fulfill PicoWay orders ... activity in Korea anticipated later in the third quarter ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: